AstraZeneca stock (AZN) has a tokenised version, AZNx, a blockchain based asset that represents AstraZeneca shares. Each AZNx token is backed 1:1 by real AstraZeneca shares held in regulated custody. AstraZeneca is a British Swedish pharmaceutical company created in 1999 through the merger of Astra and Zeneca. It focuses on medicines for cancer, heart disease, respiratory conditions and rare diseases, and it became widely known for its COVID-19 vaccine developed with the University of Oxford. It is headquartered in Cambridge, United Kingdom. Holding AZNx gives you indirect exposure to AstraZeneca shares, but it is not the same as owning the underlying shares and does not come with shareholder rights.